EP3925950
SYNTHESIS OF OMECAMTIV MECARBIL
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
29.6.2018EP published:
6.9.2023EP application number:
21174262.2
EPO information:
European Patent Register
Max expiry date:
28.6.2038
Title in English:
SYNTHESIS OF OMECAMTIV MECARBILLanguage of the patent:
English
Timeline
Today
29.6.2018EP application
6.9.2023EP Publication
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Inventor
Name:
CAILLE, SebastienAddress:
Moorpark, US
Name:
QUASDORF, KyleAddress:
Thousand Oaks, US
Name:
ROOSEN, PhilippAddress:
Thousand Oaks, US
Name:
SHI, XianqingAddress:
Newbury Park, US
Name:
COSBIE, AndrewAddress:
Ventura, US
Name:
WANG, FangAddress:
Simi Valley, US
Name:
WU, ZufanAddress:
Walnut, US
Name:
NEERGUNDA, ArchanaAddress:
Simi Valley, US
Name:
QUAN, Peter BinAddress:
Woodland, US
Name:
GUAN, LianxiuAddress:
Camarillo, US
Priority
Number:
201762527174 PDate:
30.6.2017Country:
US
Number:
201862664363 PDate:
30.4.2018Country:
US
Classification
Categories:
C07D 213/75